We use cookies for certain features and to improve your experience. See our Cookie Policy and Privacy Policy to learn more

Leafly

Shop legal, local weed.

Open
advertise on Leafly
ShopDeliveryDispensariesDealsStrainsBrandsProductsLeafly PicksCBDDoctorsCannabis 101Social impact
  • Sign in
  • Create account
  • Strains
  • Shop
  • Shop
  • Delivery
  • Deals
  • Dispensaries
  • CBD Stores
  • Brands
  • Products
  • Leafly Picks
  • Learn
  • Cannabis 101
  • News
  • Leafly Learn
  • Science of cannabis
  • Doctors
  • Social impact
  • Lab partners
  • Download the Leafly App
  • Advertise on Leafly
    • Leafly.comUSA flag
    • Leafly.caCanadian flag
  • Help
  1. Home
  2. News
  3. Politics
  4. The Shake: Don’t Bogart That Vape, Congressman
  • News
  • Cannabis 101
  • Growing
  • Strains & products
  • CBD
  • Politics
  • Health
  • Lifestyle
  • Science & tech
  • Industry
  • Reports
  • Canada
  • Podcasts
  • Leafly Lists
Politics

The Shake: Don’t Bogart That Vape, Congressman

Ben AdlinLast updated July 28, 2020

A Denver judge tossed a class action lawsuit against a top Colorado cannabis retailer. A pair of consumers had sued LivWell, alleging the company inappropriately used Eagle 20, a pesticide that contains myclobutanil, which isn’t approved for use on cannabis in the state. But Denver District Judge J. Eric Eliff threw out the case, the Denver Post reports, saying plaintiffs “bought the cannabis and consumed it” without harm. “There are no allegations that the product did not perform as it was supposed to,” Eliff wrote. LivWell owner John Lord called the lawsuit “a public relations ploy.”

California wants to tax medical cannabis. A newly proposed law would set a 15 percent tax on medical marijuana and funnel that money to public programs. The bill comes on the heels of new cannabis laws that establish statewide standards for the industry (even though nobody can agree how they work). The proposed tax, which is similar to what would be imposed under recreational laws on the ballot in November, could bring California more than $100 million in new revenue. To pass, it will need support from two-thirds of the state Legislature.

A ex-judge wants Obama to commute the harsh sentence he gave. Paul Cassell, who as a federal judge sentenced a Utah music producer to 55 years in prison for bringing a gun to cannabis deals, is calling on the president to undo the sentence. Due to mandatory minimum sentencing laws, the judge said, the offender got a longer prison term than people convicted of crimes such as kidnapping, rape, and second degree murder.

Trump’s drug policies are getting dumber and dumber. The Chicago Sun Timescompiled a collection of Trumpisms illustrating the presidential candidate’s radical shift on drug policy over the decades. “We’re losing badly the war on drugs,” he said back in 1990. “You have to legalize drugs to win that war.” Today, however, he opposes cannabis reform, having flip-flopped completely. On the campaign trail he said he’d solve the nation’s drug problem by building a wall at the U.S.–Mexico border — conveniently, also his solution to immigration.

What Would a Trump Presidency Mean for Cannabis?

Rubio’s policies might be even worse. The Republican presidential hopeful is keeping things simple, and stupid, when it comes to his stance on drugs. At a campaign event yesterday, he told voters he’s against legal cannabis “because this country already pays a terrible price for the abuse of alcohol.” Reassuring to know that the man wielding such razor-sharp logic might one day run the country.

Two Washington state cannabis producers face fines over pesticide use. Regulators temporarily barred New Leaf Enterprises and BMF Washington from selling products back in December, Tobias Coughlin-Bogue reports, pending an investigation into possible use of prohibited pesticides. Observers have questioned the state's enforcement of pesticide rules in the past, and the penalties against New Leaf and BMF show regulators could be stepping up their game.

Rep. Duncan Hunter (R-Calif.) took a defiant puff in Congress. He hit a vape pen at a House Transportation Committe hearing on Thursday as lawmakers considered a proposal that would ban vaping on airplanes. “There is nothing noxious about this whatsoever,” he told his colleagues, theatrically loosing a cloud and thereby undermining his whole point. Cannabis wasn’t part of the discussion, but whatever rules Congress adopts for e-cigarettes would likely also apply to legal cannabis products. No dice for Rep. Hunter, though — or anyone with dreams of one day vaping their way to the, uh, mile-high club. The measure passed. 

Rep. Duncan Hunter (D-Calif.) hits a vape pen in a Congressional Transportation Committee hearing.

QUICK HITS:

  • The DEA raided an Oregon extract maker. No charges have been filed yet, but it’s a reminder the feds aren’t as hands-off in legal states as they claim.
  • Cannabis-related DUI arrests in Colorado are down. Overall, the number of people cited for driving under the influence of drugs fell 1.3 percent.
  • A U.K. man diagnosed with terminal cancer says his use of illegal cannabis oil has prolonged his life.
  • CV Sciences pushed back against this week’s FDA warning letters to marketers of cannabidiol products. The agency says it’s determined that CBD isn’t a “dietary supplement,” but CV, which makes hemp-derived CBD for use in consumer products, argues the warnings are “inapplicable” on technical grounds.
  • Medical marijuana in Florida could be a $1.5 billion industry by 2020, according to a new report. Voters will decide in November whether to legalize medical cannabis.
  • Don’t try singing “Smoke Weed Everyday” in Tunisia. Lawmakers there are considering plans to crack down on “public incitement to commit drug-related offenses,” which could make it illegal to even talk about cannabis.

The Shake: Roseanne Gets in the Biz, Chris & Christie Get Out

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • See all dispensaries
See all dispensaries
Barack ObamaCaliforniadonald trumppesticidespoliticsrounduptaxesThe ShakeWashington
Ben Adlin
Ben Adlin
Ben Adlin is a Seattle-based writer and editor who specializes in cannabis politics and law. He was a news editor for Leafly from 2015-2019. Follow him on Twitter: @badlin
View Ben Adlin's articles

The latest in Politics

  • Cannabis rescheduling just sped up: What you need to know about the executive order image
    Cannabis rescheduling just sped up: What you need to know about the executive order
    Morgan Rosendale
  • How US import tariffs are impacting cannabis prices and products image
    How US import tariffs are impacting cannabis prices and products
    Leafly Staff
  • Ohioans must activate to defend cannabis freedoms from lawmakers image
    Ohioans must activate to defend cannabis freedoms from lawmakers
    David Downs
  • Montanans must activate to protect legalization in 2025 image
    Montanans must activate to protect legalization in 2025
    David Downs
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

Something went wrong, please try again.

By providing us with your email address, you agree to Leafly’s Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App StoreDownload Leafly Marijuana Reviews on Google Play

Business Solutions
  • List your store
  • List your CBD store
  • List your brand
  • List your practice
  • Business log in

About Leafly
  • About us
  • Careers
  • Newsroom
  • Investor relations
  • Contact us
  • FAQs
  • Accessibility

Dispensaries in
  • Los Angeles
  • Seattle
  • Portland
  • San Francisco
  • Toronto
  • Detroit

Privacy & Terms
  • Terms of use
  • Commercial terms of use
  • Privacy policy
  • Do not sell my personal information

* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2026 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.